660 related articles for article (PubMed ID: 15200495)
41. Overexpression of peroxisome proliferator-activated receptor-alpha (PPARalpha)-regulated genes in liver in the absence of peroxisome proliferation in mice deficient in both L- and D-forms of enoyl-CoA hydratase/dehydrogenase enzymes of peroxisomal beta-oxidation system.
Jia Y; Qi C; Zhang Z; Hashimoto T; Rao MS; Huyghe S; Suzuki Y; Van Veldhoven PP; Baes M; Reddy JK
J Biol Chem; 2003 Nov; 278(47):47232-9. PubMed ID: 14500732
[TBL] [Abstract][Full Text] [Related]
42. Vitamin D attenuates high fat diet-induced hepatic steatosis in rats by modulating lipid metabolism.
Yin Y; Yu Z; Xia M; Luo X; Lu X; Ling W
Eur J Clin Invest; 2012 Nov; 42(11):1189-96. PubMed ID: 22958216
[TBL] [Abstract][Full Text] [Related]
43. Dietary lipids regulate beta-oxidation enzyme gene expression in the developing rat kidney.
Ouali F; Djouadi F; Merlet-Bénichou C; Bastin J
Am J Physiol; 1998 Nov; 275(5):F777-84. PubMed ID: 9815135
[TBL] [Abstract][Full Text] [Related]
44. Peroxisome proliferator-activated receptor alpha is involved in the regulation of lipid metabolism by ginseng.
Yoon M; Lee H; Jeong S; Kim JJ; Nicol CJ; Nam KW; Kim M; Cho BG; Oh GT
Br J Pharmacol; 2003 Apr; 138(7):1295-302. PubMed ID: 12711630
[TBL] [Abstract][Full Text] [Related]
45. PPARalpha-dependent induction of liver microsomal esterification of estradiol and testosterone by a prototypical peroxisome proliferator.
Xu S; Zhu BT; Turan V; Rusyn I; Thurman R; Peters JM; Gonzalez FJ; Conney AH
Endocrinology; 2001 Aug; 142(8):3554-7. PubMed ID: 11459802
[TBL] [Abstract][Full Text] [Related]
46. Treatment with pharmacological peroxisome proliferator-activated receptor alpha agonist clofibrate causes upregulation of organic cation transporter 2 in liver and small intestine of rats.
Ringseis R; Pösel S; Hirche F; Eder K
Pharmacol Res; 2007 Aug; 56(2):175-83. PubMed ID: 17644405
[TBL] [Abstract][Full Text] [Related]
47. Differential regulation of peroxisome proliferator-activated receptor (PPAR)-alpha1 and truncated PPARalpha2 as an adaptive response to fasting in the control of hepatic peroxisomal fatty acid beta-oxidation in the hibernating mammal.
El Kebbaj Z; Andreoletti P; Mountassif D; Kabine M; Schohn H; Dauça M; Latruffe N; El Kebbaj MS; Cherkaoui-Malki M
Endocrinology; 2009 Mar; 150(3):1192-201. PubMed ID: 18948393
[TBL] [Abstract][Full Text] [Related]
48. The peroxisomal beta-oxidation enzyme system of rat heart. Basal level and effect of the peroxisome proliferator clofibrate.
Kvannes J; Eikhom TS; Flatmark T
Biochim Biophys Acta; 1994 Nov; 1201(2):203-16. PubMed ID: 7947933
[TBL] [Abstract][Full Text] [Related]
49. Acyl-CoA esters antagonize the effects of ligands on peroxisome proliferator-activated receptor alpha conformation, DNA binding, and interaction with Co-factors.
Elholm M; Dam I; Jorgensen C; Krogsdam AM; Holst D; Kratchmarova I; Gottlicher M; Gustafsson JA; Berge R; Flatmark T; Knudsen J; Mandrup S; Kristiansen K
J Biol Chem; 2001 Jun; 276(24):21410-6. PubMed ID: 11279171
[TBL] [Abstract][Full Text] [Related]
50. PPAR: a mediator of peroxisome proliferator action.
Green S
Mutat Res; 1995 Dec; 333(1-2):101-9. PubMed ID: 8538617
[TBL] [Abstract][Full Text] [Related]
51. Mechanisms Mediating the Regulation of Peroxisomal Fatty Acid Beta-Oxidation by PPARα.
Tahri-Joutey M; Andreoletti P; Surapureddi S; Nasser B; Cherkaoui-Malki M; Latruffe N
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445672
[TBL] [Abstract][Full Text] [Related]
52. Expression of putative fatty acid transporter genes are regulated by peroxisome proliferator-activated receptor alpha and gamma activators in a tissue- and inducer-specific manner.
Motojima K; Passilly P; Peters JM; Gonzalez FJ; Latruffe N
J Biol Chem; 1998 Jul; 273(27):16710-4. PubMed ID: 9642225
[TBL] [Abstract][Full Text] [Related]
53. Effect of ursolic acid and Rosiglitazone combination on hepatic lipid accumulation in high fat diet-fed C57BL/6J mice.
Sundaresan A; Radhiga T; Pugalendi KV
Eur J Pharmacol; 2014 Oct; 741():297-303. PubMed ID: 25149666
[TBL] [Abstract][Full Text] [Related]
54. Involvement of the peroxisome proliferator-activated receptor alpha in regulating long-chain acyl-CoA thioesterases.
Hunt MC; Lindquist PJ; Peters JM; Gonzalez FJ; Diczfalusy U; Alexson SE
J Lipid Res; 2000 May; 41(5):814-23. PubMed ID: 10787442
[TBL] [Abstract][Full Text] [Related]
55. Defect in peroxisome proliferator-activated receptor alpha-inducible fatty acid oxidation determines the severity of hepatic steatosis in response to fasting.
Hashimoto T; Cook WS; Qi C; Yeldandi AV; Reddy JK; Rao MS
J Biol Chem; 2000 Sep; 275(37):28918-28. PubMed ID: 10844002
[TBL] [Abstract][Full Text] [Related]
56. N-3 long-chain PUFA supplementation prevents high fat diet induced mouse liver steatosis and inflammation in relation to PPAR-α upregulation and NF-κB DNA binding abrogation.
Tapia G; Valenzuela R; Espinosa A; Romanque P; Dossi C; Gonzalez-Mañán D; Videla LA; D'Espessailles A
Mol Nutr Food Res; 2014 Jun; 58(6):1333-41. PubMed ID: 24436018
[TBL] [Abstract][Full Text] [Related]
57. Polyunsaturated fatty acid suppression of hepatic fatty acid synthase and S14 gene expression does not require peroxisome proliferator-activated receptor alpha.
Ren B; Thelen AP; Peters JM; Gonzalez FJ; Jump DB
J Biol Chem; 1997 Oct; 272(43):26827-32. PubMed ID: 9341113
[TBL] [Abstract][Full Text] [Related]
58. Effect of clofibrate on fatty acid metabolism in the kidney of puromycin-induced nephrotic rats.
Muroya Y; Ito O
Clin Exp Nephrol; 2016 Dec; 20(6):862-870. PubMed ID: 26949064
[TBL] [Abstract][Full Text] [Related]
59. Presence and features of fatty acyl-CoA binding activity in rat hepatic peroxisomes.
Hashimoto F; Hayashi H
J Biochem; 2002 Mar; 131(3):453-60. PubMed ID: 11872175
[TBL] [Abstract][Full Text] [Related]
60. Mechanisms of peroxisome proliferation by perfluorooctanoic acid and endogenous fatty acids.
Intrasuksri U; Rangwala SM; O'Brien M; Noonan DJ; Feller DR
Gen Pharmacol; 1998 Aug; 31(2):187-97. PubMed ID: 9688458
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
